Express Pharma

JUNE 12, 2025

It places way more emphasis on hands- on training for pharmaceutics, medicinal chemistry, and pharmaceutical analysis while sidelining practicals in foundational sciences like human anatomy, physiology, patho- physiology, and clinical pharmacology. The collab- oration between industry and academia in drug development.

Drug Development

European Pharmaceutical Review

MARCH 11, 2024

About the author Sherene Min, MD, MPH, is Vice President of Global Clinical Development at ViiV Healthcare , a role she assumed in October 2019. With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety.

Immunity

Putting Patients First Blog

SEPTEMBER 26, 2024

Further discussion on the unique aspects of rare disease drug development, the associated challenges, and when waivers may be warranted would greatly benefit all stakeholders, including sponsors, patient organizations, clinical researchers, and regulators. NHC comments on FDA diversity in clinical trials guidance.

Communication

Pharmaceutical Technology

DECEMBER 16, 2022

This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology. The post 2022 in review: Drug development milestones for tropical diseases appeared first on Pharmaceutical Technology.

Drug Development